Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026.

Dr. Matthew Galsky spoke with CURE about the KEYNOTE-B15 trial results and their potential impact on muscle-invasive bladder cancer care. At the 2026 ASCO Genitourinary Cancers Symposium, the ...

AngioDynamics ANGO has been gaining from its solid prospects with NanoKnife and an increased focus on cancer treatment markets. The optimism, led by a solid first-quarter fiscal 2026 performance, ...

Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

Clinically known as benign prostatic hyperplasia (BPH), enlarged prostate is a non‑cancerous condition that affects roughly half of men ages 51 to 60, with incidence increasing ...

Axogen, Inc. (AXGN) 47th Annual Raymond James Institutional Investor Conference March 3, 2026 3:25 PM ESTCompany ParticipantsMichael Dale - President, ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, ...

Targeted ultrasound therapy offers a less invasive prostate cancer treatment designed to minimize disruption to daily life.

In 2025, adults aged 25-34 FAIR Health Consumer, while adults 65 and older (the largest user group in 2024) remained a high proportion of users. FAIR Health Consumer (fairhealthconsumer.org) is FAIR ...

Health care prices are on the rise, and patients are flummoxed that even insurance companies aren’t doing more to control costs.

In the world of surgical robots, there’s a new kid in town, and Atrium Health Wake Forest Medical Center is one of the first ...